Extent of oxidative modification of low density lipoprotein determines the degree of cytotoxicity to human coronary artery cells

Heart

Volumn 75, Issue 1, 1996, Pages 11-16

  Thorne, S A ^a,b   Abbot, S E ^a   Winyard, P G ^a   Blake, D R ^a   Mills, P G ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Coronary artery; Cytotoxicity; Oxidised low density lipoprotein

Indexed keywords

BROXURIDINE; LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL MIGRATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOTOXICITY; ENDOTHELIUM; ENDOTHELIUM LESION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID OXIDATION; MORPHOLOGY; PRIORITY JOURNAL;

EID: 0030040950     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.75.1.11     Document Type: Article

References (33)

1. Stary H. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 1989;9(suppl 1):I1-19.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
3. Richardson P, Davies M, Born G. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989;ii:941-4.
4. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation 1995; 91:2703-11.
5. Morel DW, Hessler JR, Chislom GM. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res 1983;24:1070-6.
6. Hiramatsu K, Rosen H, Heinecke JW, Wolfbauer G, Chait A. Superoxides initiate oxidation of low density lipoprotein by monocytes. Arteriosclerosis 1987;7:55-60.
7. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, et al. Minimally low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 1990;85:1260-6.
8. Esterbauer H, Dieber-Rotheneder M, Waeg G, Striegel G, Jürgens G. Biochemical, structural and functional properties of oxidised low-density lipoprotein. Chem Res Toxicol 1990;3:77-92.
9. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979;76: 333-7.
10. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 1987;84:2995-8.
11. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, et al. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low density lipoproteins. Nature 1990;344:254-7.
12. Boulanger CM, Tanner FC, Béa ML, Hahn AWA, Werner A, Lüscher TF. Oxidised low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res 1992;70:1191-7.
13. Simon BC, Cunningham LD, Cohen RA. Oxidised low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 1990;86:75-9.
14. Flavahan NA. Atherosclerosis or lipoprotein-induced endothelial dysfunction. Circulation 1992;85(5):1927-37.
15. Latron Y, Chautan M, Anfosso F, Alessi MC, Nalbone G, Lafont H, et al. Stimulating effect of oxidised low density lipoproteins on plasminogen activator inhibitor-1 synthesis by endothelial cells. Arterioscler Thromb 1991;11(6): 1821-9.
16. Drake TA, Hannani K, Fei H, Lavi S, Berliner JA. Minimally modified low density lipoprotein induce tissue factor expression in cultured human endothelial cells. Am J Pathol 1991;138(3):601-7.
17. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973;52:2745-6.
18. Smirnov VN, Orekhov AN. Smooth muscle cells from adult human aorta. In: Piper HM, ed. Cell culture techniques in heart and vessel research. New York: Springer-Verlag, 1990:271-89.
19. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-53.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265.
21. Territo MC, Berliner JA, Almada L, Ramirez R, Fogelman AM. β-very low density lipoprotein pretreatment of endothelial monolayers increases monocyte adhesion. Arteriosclerosis 1989;9:824-8.
22. Navab M, Imes SS, Hama SY, Gough GP, Ross LA, Bork RW, et al. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest 1991;88: 2039-46.
23. Parthasarathy S, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1990;1044:275-83.
24. Ludwig JD, Avis KE. Dry heat inactivation of endotoxin on the surface of glass. J Parenter Sci Technol 1990;44(1): 4-12.
25. Yin ET, Galanos C, Kinsky S, Bradshaw RA, Wessler S, Lüderitz O, et al. Picogram-sensitivity assay for endotoxin: gelation of Limulus polyphemus blood cell lysate induced by purified lipopolysaccharides and lipid A from gram-negative bacteria. Biochim Biophys Acta 1972;261: 284-9.
26. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987;87:1188-92.
27. Wellicome SM, Thornhill MH, Pitzalis C, Thomas DS, Lanchbury JSS, Panayi GS, et al. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumour necrosis factor, IL-1, or lipopolysaccharide. J Immunol 1990;144:2558-65.
28. Esterbauer H, Dieber-Rotheneder M, Waeg G, Puhl H, Tatzber F. Endogenous antioxidants and lipid peroxidation. Biochem Soc Trans 1990;18:1059-61.
29. Yagi K. Assay for serum lipid peroxide level and its clinical significance. In: Lipid peroxides in biology and medicine. New York: Academic Press, 1982:223-42.
30. Thorne SA, Abbot SE, Blake DR, Mills PG. Human recombinant tissue-type plasminogen activator enhances wound healing in human coronary artery endothelial cells [abstract]. Br Heart J 1992;68(1): 94.
31. Havel RJ Kane JP. Structure and metabolism of plasma lipoproteins. In: Schriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. New York: McGraw-Hill, 1989:1129-38.
32. Stiko-Rahm A, Hultgardh-Nilsson A, Regnstrom J, Hamsten A, Nilsson J. Native and oxidised LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human SMCs. Arterioscl Thromb 1992;12(9):1099-109.
33. Harris-Hooker S, Sanford GL, Montgomery V, Rivers R, Emmett N. Influence of low density lipoproteins on vascular smooth muscle. Cell Biol Int Rep 1992;16(5): 433-50.